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Summary 
In a number of experimental systems in which lymphocyte depletion was induced by apoptosis- 
inducing manipulations, no apoptotic morphology and ladder-type DNA fragmentation were 
detected among freshly isolated peripheral lymphocytes ex vivo. Here we report that one altera- 
tion that can be detected among splenocytes stimulated with lymphocyte-depleting doses of dexa- 
methasone (DEX) in vivo is a reduced uptake of 3,3'dihexyloxacarbocyanine iodide (DiOC6[3]), 
a fluorochrome which incorporates into cells dependent upon their mitochondrial transmem- 
brane potential (A~m). In contrast, ex vivo isolated splenocytes still lacked established signs of 
programmed cell death (PCD): DNA degradation into high or low molecular weight fragments, 
ultrastructural changes of chromatin arrangement and endoplasmatic reticulum, loss in viability, 
or accumulation of intracellular peroxides. Moreover, no changes in cell membrane potential 
could be detected. A reduced A~m has been observed in response to different agents inducing 
lymphoid cell depletion in vivo (superantigen and glucocorticoids [GC]), in mature T  and B 
lymphocytes, as well as their precursors. DEX treatment in vivo, followed by cytofluorometric 
purification of viable A~m  l~  splenic T  cells ex vivo,  revealed that this fraction of cells is irre- 
versibly committed to undergoing DNA fragmentation. Immediately after purification neither 
A~m  l~  nor  AlI;mhigh cells, exhibit detectable DNA fragmentation. However, after short-term 
culture (37~  1 h) A~m  l~  cells show endonucleolysis, followed by cytolysis several hours later. 
Incubation of AlICml~  cells in the presence of excess amount of the GC receptor antagonist RU- 
38486  (which displaces DEX from the GC receptor), cytokines that inhibit DEX-induced cell 
death, or cycloheximide fails to prevent cytolysis.  The antioxidant, N-acetylcysteine, as well as 
linomide, an agent that effectively inhibits DEX or superantigen-induced lymphocyte depletion 
in vivo, also stabilize  the DiOC6(3) uptake. In contrast, the endonuclease inhibitor, aurintricar- 
boxylic acid acts  at later stages  of apoptosis  and only retards the transition from the viable 
AlICml~  to the nonviable fraction. Altogether, these data suggest a sequence of PCD-associated 
events in which a reduction in A~m constitutes an obligate irreversible step of ongoing lym- 
phocyte death, preceding other alterations of cellular physiology, and thus allowing for the ex 
vivo assessment of PCD. 
I 
t is currently assumed that lymphocyte elimination nor- 
mally involves programmed cell death (PCD) 1 (1). This 
notion is supported by two observations. First, a large panel 
of  stimuli  (antigen-  and  coreceptor-mediated  activation, 
1  Abbreviations used in 'this  paper: ATA, aurintricarboxylic  acid; Aa/~, mi- 
tochondrial  transmembrane  potential; DEX, dexamethasone;  DCFH-DA, 
2',7'-dichlorofluorescin diacetate; DiBAC4(3), bis-(1-3-dibutylbarbityric 
acid)trimethixine  oxonol; DiOC6(3), 3,Ydihexyloxacarbocyanine  iodide; 
GC, glucocorticoid;  mC1CCP, carbamoyl  cyanide  m-chlorophenylhydra- 
zone; NAC,  N-acetylcysteine;  PCD, programmed  cell  death; PI, propidium 
iodide; Rh123, rhodamine  123; SEB, Staphylococcus  aureus enterotoxin  B. 
cytokines, hormones, cytotoxic drugs, physical damage, etc.) 
that deplete lymphocytes in vivo also causes lymphocyte apop- 
tosis in vitro (1, 2).  Second, lymphocyte depletion in vivo 
is accompanied by an enhanced apoptotic decay of lympho- 
cytes kept in culture during several hours ex vivo. This latter 
observation  applies  to  rather  disparate  systems,  such  as 
superantigen-induced depletion of mouse T  cells  (3),  cir- 
culating leukemia cells  from patients  receiving apoptosis- 
inducing chemotherapy (4, 5), and peripheral blood lympho- 
cytes from HIV carriers (6, 7). However, in several of these 
experimental systems,  no morphological signs of apoptosis 
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among peripheral lymphocytes without previous in vitro cul- 
ture, even when lymphocytes were isolated ex vivo during 
the phase of in vivo depletion (3-7). To reveal the "ladder- 
type" DNA fragmentation, in many systems, cells must be 
cultured during a short period at 37~  in vitro (3,  6,  7). 
The apparent discrepancy between in vitro and in vivo data 
concerning apoptosis in peripheral lymphoid organs may be 
hypothetically resolved by assuming migration of preapop- 
totic ceils or the efficient engulfment and rapid degradation 
of dying cells by intact adjacent cells in situ, before apoptosis 
and endonucleolysis become manifest (8). 
With these facts in mind, we decided to search for altera- 
tions in lymphoid physiology that reveal commitment to PCD 
in vivo. We applied a fluorescence-based  method for the de- 
termination  of  mitochondrial  transmembrane  potential 
(Aft'm) (9)  to lymphocytes undergoing PCD in vivo.  Our 
data indicate a  strict correlation between a partial loss  in 
AXItm and later entrance into apoptosis in vitro and/or elimi- 
nation of cells in vivo. This allows for the quantitative assess- 
ment of ongoing lymphocyte PCD ex vivo, i.e., without the 
necessity of in vitro culture. Moreover, a characterization of 
the temporal and causal relationship between alterations in 
AxIttm and other PCD-associated events  is reported in this 
paper. 
Materials and Methods 
Animals and ln Vivo Treatment:  8-10-wk-old  female  BALB/c mice 
received injections of the superantigen Staphylococcus aureus en- 
terotoxin B (SEB) (50 #g in 200/zl PBS i.v.) (Sigma Chemical Co., 
St. Louis, MO), dexamethasone (DEX) (500/~g in 200 #1 PBS 
i.p.) (Sigma Chemical Co.). Linomide (kindly provided by Dr. T. 
Kalland; Pharmacia LKB, Uppsala, Sweden) was administered to- 
gether with the drinking water (300 mg/kg per day, 2-3 d before 
inducing apoptosis by DEX or SEB as described (10). N-acetyl- 
cysteine (NAC) was administered orally (1 or 3 g/kg per d, in the 
drinking water) 24 h before injection of DEX (11). Aurintricar- 
boxylic acid (ATA) was administered 4 and 2 h before DEX at a 
dose (2  x  1.5 mg i.p.) that completely inhibits oligonucleosomal 
DNA fragmentation in vivo (12). 
Isolation of Cells and In Vitro Culture.  Thymuses, spleens, and 
femurs were immediately  transferred  to petri dishes  containing  HBSS 
kept on ice. Monocellular suspensions were prepared and washed 
as described (13), while the temperature was kept continuously be- 
tween 0 and 4~  until staining or culture. Erythrocytes were elim- 
inated from splenic and bone marrow cell suspensions by hypo- 
tonic shock at 0~  and splenic T cells were obtained by panning 
of B cells, using plastic-immobilized  rabbit anti-IgM (Southern Bio- 
technology Associates, Birmingham, AL) as described (3). Cells 
(1-2  x  106/ml) were cultured in medium (RPMI  1640, supple- 
merited with 5% FCS, L-glutamine,  and antibiotics)  at 37~  during 
the indicated period in the presence or absence of 100 nM DEX, 
10 tim RU-38486 (kindly provided by Dr. Martini, Roussel Uclaf, 
Romainville, France), 100 U/ml IL-2 (kindly provided by Dr. M. 
Galiay, Roussel Uclaf), 20 ng/ml IL-4 (Prepro Tech, Inc., Rocky 
Hill, NJ), and/or 50/~g/ml cycloheximide  (Sigma Chemical Co.). 
Assessment  of Cellular and Mitochondrial Potentials, Intraceltular 
Peroxides, Membrane Peroxidation, Cell Viability, and DNA  Content. 
Cell membrane potentials were measured by means of bis-(1-3- 
dibutylbarbityric acid)trimethixine oxonol (DiBAC4[3]) (Molec- 
ular Probes Inc., Eugene, OR) (14). 5 x  10  s cells were incubated 
for 10 min at 370C in 1 ml of 150 nM DiBAC4(3), before cyto- 
fluorometric analysis  using a cytofluorometer  previously  equilibrated 
with the oxonol dye (Epics Profile; Coulter Corp., Hialeah, FL) 
with excitation and emission settings of 488 and 525 nm, respec- 
tively. To evaluate A~m, cells (5  x  10S/ml) were incubated with 
3,3'-dihexyloxacarbocyanine  iodide (DiOC6[3]) (40 nM in PBS; 
Molecular Probes, Inc.) for 15 min at 37~  (9), followed by anal- 
ysis on a cytofluorometer (Epics Profile, excitation: 488 nm; emis- 
sion: 525 nm). Alternatively, cells were incubated for 20 min at 
37~  in 50 ng/ml rhodamine 123 (Rh123) to measure Ag/m by 
cytofluorometry  (excitation: 488 nm; emission:  525 nm) (15). Con- 
trol experiments  were performed  in the presence of 5 #M carbamoyl 
cyanide m-chlorophenylhydrazone (mC1CCP) (15  min,  37~ 
an uncoupling agent that abolishes the A~m. Intracellular per- 
oxides were measured by means of 2',7'-dichlorofluorescin diace- 
tate (DCFH-DA) (Molecular  Probes Inc.; 5/xM in PBS; 1 h, 37~ 
excitation: 488 nm; emission: 525 nm), as described (16). For the 
determination of lipid peroxidation, 5 x  106 cells were incubated 
with 5 #M cis-parinaric acid (Molecular Probes Inc.) in PBS (1 h, 
37~  washed twice and resuspended in complete medium in the 
presence or absence of DEX (1/zM) for the indicated period, and 
analyzed by cytofluorometry (excitation: 334-364 nm; emission: 
410 nm) on a cytofluorometer (Elite; Coulter Corp.) (17). To de- 
termine the integrity of the cell membrane, cells were incubated 
for 10 min in propidium iodide (PI) (5 #g/ml in PBS) at 37~ 
For cell cycle analysis, 2  x  106 cells were spun down and fixed 
in 70% ice-cold  ethanol/PBS, added  dropwise while vortexing, kept 
overnight at 4~  and centrifuged. Cells were resuspended  in 1 ml 
PBS containing 50/~g/ml PI and analyzed in a cytofluorometer 
(Epics Profile). 
Cytofluorometric Purification of DiOC6(3)  ~  and DiOC~(3)~g  k Cells. 
Splenic T cells were stained for 15 rain with DiOC6(3) (40 nM, 
37~  During the last 5 rain of this incubation period, PI was 
added (5 #g/m1). Cells were sorted immediately on a cytofluoro- 
meter (Elite) (104 cellsA) and recovered in complete medium on ice. 
Immunofluorescence Analysis.  Cells were stained with mAbs 
directed against CD3e (145-Cll), CD4 (RM4-5), CD8c~ (53-6.7), 
V~/6 (RR4-7), VB8.1, and 8.2 (MR5-2) or anti-IgM  ~  (DS-1; Phar- 
Mingen, San Diego, CA), which were either PE-labeled or biotin- 
conjugated and developed by means of streptavidin-PE (GIBCO- 
BRL,  Gaithersburg, MD),  as described (13). Isotype-matched 
control antibodies served as negative controls. Mitochondrial F~ 
ATPase expression was determined by cytofluorometry on permea- 
bilized cells (70% methanol in PBS, 30 min at  -20~  followed 
by two washings in PBS), using optimal concentrations of  a specific 
polyclonal  rabbit antiserum (kindly provided by Dr. P. V. Vignais, 
Centre National de la Recherche  Scientifique-URA  1130, Grenoble, 
France) revealed  by an FITC-labeled af~nity purified F(ab')2 frag- 
ment donkey anti-rabbit IgG (Jackson ImmunoResearch Labora- 
tories, Inc., West Grove, PA). Preliminary experiments on murine 
fibroblasts revealed  specific  mitochondrial staining patterns, using 
this combination of antibodies. 
Assessment of DNA Fragmentation and Electron Microscot~/.  To 
determine oligonucleosomal DNA fragmentation, nuclear DNA 
from lysed cells treated with protease K and RNAse, according 
to standard protocols, was subjected to conventional horizontal 
agarose gel electrophoresis (1%), followed by ethidium bromide 
staining (3, 13). For PAGE  electrophoresis, DNA was prepared from 
agarose plugs (1  x  106 cells) (18) digested twice with proteinase 
K (1 mg/ml, 50~  12 h) in NDS buffer (0.5 M EDTA, 10 mg/ml 
lauroyl sarcosine) and washed in Tris-buffered  EDTA x  0.5, fol- 
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Richmond, CA) (1% agarose,  TBE x 0.5, 200 V, 24 h, pulse wave 
60 s, 120  ~ angle). Mol wt standards were purchased from BioRad 
Laboratories, Inc. (yeast chromosomes) and Appligene (Raoul; 
Illkirch, France). To assess zinc-resistant changes in ultrastructure 
and DNA configuration, cells were cultured in the presence of 1 
mM ZnC12 and/or 1/zM DEX, followed  by PAGE electrophoresis 
or fixation  in 2% glutaraldehyde  in 0.1 M sodium cacodylate  buffer 
(pH 7.2), osmium tetroxide staining, and electron microscopic  ex- 
amination as described (19). 
Immunochemical Determination of Mitochondrial ATPase Expres- 
sion.  Cells  were rinsed twice in cold PBS and lysed  by addition 
of 0.5%  NP-40. Crude extracts, normalized for protein content 
(60/zg protein/lane), were subjected  to SDS-PAGE in 7.5% acryl- 
amide and 0.1% bisacrylamide,  followed by Western blot transfer 
to nitrocellulose membranes (20). Expression of mitochondrial F1 
ATPase was determined by means of a specific polyclonal rabbit 
antiserum  revealed by  a  second peroxidase-conjugated goat 
anti-rabbit Ig serum (BioSys,  Compi~gne, France) for I h at room 
temperature. The immunoreactivity  was revealed  using the enhanced 
chemoluminescence  kit (Amersham  Corp., Arlington Heights, IL) 
(time of exposure: 2 rain). 
Results and Discussion 
Reduction in A grm of Splenocytes Can Be Detected Ex  Vivo 
after Injection ofDEX.  Thymocytes and splenocytes rapidly 
underwent apoptosis upon exposure to glucocorticoid (GC) 
in vitro (21, 22). However, splenocytes recovered from animals 
treated with high doses of DEX in vivo did not exhibit DNA 
fragmentation or hypoploidy after isolation ex vivo,  even 
during the phase of  lymphoid cell depletion, unless they were 
cultured during a short period (~60 min) at 37~  (Fig.  1). 
Splenocytes recovered from animals  12 h after the injection 
of 500/zg DEX exhibited an intact DNA content, as deter- 
mined by PI staining of permeabilized cells. Moreover, they 
possessed a normal electric potential of the cell membrane, 
as determined with DiBAC4(3),  an agent that incorporates 
into cells strictly dependent upon their external cell mem- 
brane potential (14). Furthermore, at this time point, no in- 
crease in the concentration of intraceUular  peroxides could 
be detected by means of DCFH-DA. 
In contrast, splenocytes from DEX-treated mice exhibited 
a  reduction  in  the  incorporation  of  the  fluorochrome 
DiOC6(3),  as compared to cells from control animals (Fig. 
1).  DiOC6(3)  incorporated  into  cells  in  strict  nonlinear 
correlation with AXI/m  (9).  mC1CCP, an uncoupler of the 
oxidative phosphorylation that  abolishes  A~m,  abolished 
staining with DiOC6(3), demonstrating that the dye uptake 
was driven by A~m and did not involve significant binding 
to other cellular components (Fig.  1, upper left). A fraction 
of viable  (PI-)  control cells from vehicle-injected animals 
(15-25%) showed a reduced DiOC6(3) uptake, as compared 
to the principal population, correlating with the fact that 
a significant percentage of splenocytes underwent PCD spon- 
taneously  (Fig.  2  D)  (22).  However,  the  percentage  of 
DiOC6(3)  l~  cells was much higher among splenocytes from 
DEX-treated animals (Fig.  1).  Analogous results were ob- 
tained with other cationic fluorochromes commonly used for 
Figure 1.  Alterations  detectable  among  splenic  lymphocytes  primed  for 
cell death  in vivo. Splenocytes  were recovered from animals treated 12 h 
before with 500 #g DEX i.p. or PBS and stained by incubation with 
DiBAC4(3), DiOC6(3), Rh123, DCFH-DA, PI, or an antiserum  specific 
for mitochondrial  F1 ATPase. The distribution of viable (PI-) cells is 
shown for DiBAC4(3), DiOC6(3), and DCFH-DA. For DiOC6(3) and 
ILh123, negative  controls (cells treated with mCICCP) are shown. For 
DCFH-DA, a positive control (cells kept 2 min in 15 mM H202 and 
washed three times) was inserted. F1 ATPase was determined  by immu- 
nofluorescence,  using  methanol-permeabilized  cells.  Controls  were  incubated 
with a nonimmune  rabbit antiserum. DNA content was quantified  by 
means of PI staining  of ethanol-permeabilized  cells. DNA fragmentation 
was assessed  by horizontal  agarose  gel electrophoresis,  followed  by staining 
with ethidium  bromide. DNA was analyzed  from either ex vivo isolated 
cells or from  cells  kept in culture  for 60 min at 37~  Data are representa- 
tive for five different  experiments. 
the quantification of A~Itm: Rh123 (Fig. 1) (15) and 5,5',6,6'- 
tetrachloro- 1,1',3,3'-tetraethylbenzimidazolcarbocyanine iodide 
(23) (not shown). Staining of cells with an antibody-recog- 
nizing  mitochondrial F1  ATPase revealed  no  quantitative 
difference between DEX-treated and control splenocytes, in- 
dicating that no loss of mitochondrial mass occurs during 
PCD  (Fig.  1). 
Kinetics of Alterations in A ~m and In Vivo Detection of Re- 
duced ,4 ~m.  To determine  the temporal relationship between 
loss in A~m and established signs of ongoing PCD, we ana- 
lyzed the kinetics of these phenomena in vitro and in vivo. 
In both splenocytes  and thymocytes, endonucleolytic DNA 
fragmentation, associated  hypoploidy, loss in cell viability, 
and membrane lipid peroxidation induced by DEX in vitro 
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of DNA hypoploidy (PI staining of ethanol-fixed cells) or A~m (DiOCr(3) incorporation).  In addition, lipid peroxidation was determined by means 
of cis-parinaric  acid. (A) Kinetics of DEX-induced alterations in thymocytes and sptenocytes ex vivo. Mice received 500/zg DEX i.p. and were killed 
at the indicated time points (two to three mice per point, X  -+ SEM). Loss in cell viability was determined by PI staining, loss in A~m by staining 
with DiOC6(3),  and hypoploidy by PI staining of ethanol-fixed cells (see Fig. 1). The percentage of A'~/ml~ cells was calculated among the viable 
fraction of cells. Loss in cellularity was determined by calculating the total number of viable (trypan blue-negative) thymocytes or splenocytes and 
comparing them to age- and sex-matched untreated controls. Cell suspensions were prepared while keeping organs on ice and were directly subjected 
to analysis ex vivo. (B) DNA fragmentation of freshly isolated thymocytes or splenocytes after injection of DEX (same suspensions as in A). After 
injection of DEX in vivo, cell suspensions were prepared after the indicated interval. DNA fragmentation was assessed by horizontal agarose gel elec- 
trophoresis. Data are representative for five different experiments. (C) Stable expression of mitochondrial F1 ATPase in cells undergoing apoptosis. 
Freshly isolated splenocytes or cells cultured 18 h in the presence (90% PI + cells) or absence (52% PI + cells) of 100 nM DEX were analyzed by immu- 
noblot  using a polyclonal antiserum recognizing both the et and the t3 subunits of F1 ATPase ("~55 kD).  (D) Kinetics of DEX-induced alterations 
in vitro. Splenic lymphocytes from untreated animals were cultured in the presence or absence of DEX (100 nM) during the indicated period, followed 
by determination of the different parameters. The percentage of A~m  I~  cells was calculated among the viable (PI-) fraction of cells. (E) Determina- 
tion of lipid peroxidation induced by treatment with DEX in vitro. Splenocytes  were labeled with cis-parinaric acid, cultured in the presence or absence 
of DEX (100 nM) for the indicated period,  and analyzed by cytofluorometry. 
were preceded by a reduction in A~m (Fig.  2). This applied 
to both  PCD  occurring  in  vivo  (Fig.  2,  A  and  B)  and  in 
vitro  (Fig.  2  D).  Splenocytes  isolated  ex  vivo  exhibited  a 
significant  reduction  in A~m as little as 4  h  after injection 
of DEX (Fig. 2 A). This applied also to thymocytes 4 h after 
injection of DEX, i.e., at a time point at which no significant 
loss in cellularity had occurred and neither DNA fragmenta- 
tion,  nor  hypoploidy,  could  be detected  ex vivo, yet A~m 
was already perturbed.  In contrast to splenocytes, thymocytes 
did display advanced stages of apoptosis,  such as DNA  flag- 
mentation and hypoploidy ex vivo, 8 h after injection of DEX. 
However,  kinetic  analysis  revealed  that  reduced  DiOC6(3) 
incorporation preceded  these alterations  (Fig.  2, A  and B). 
Only when the percentage of nonviable (PI +) cells increased 
in culture,  did the frequency of DiOC6(3) l~  decrease among 
the  viable  (PI-)  population,  indicating  that  DiOC6(3) l~ 
PI-  cells were recruited  into the pool of PI §  cells.  In vitro 
induction of PCD in splenocytes also revealed a loss in AkOm 
before cells lost their viability and chromosomal DNA  was 
digested. (Fig. 2 D). 4 h after culture with DEX, a significant 
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lipid peroxidation could be determined by means of the fluores- 
cent dye c/s-parinaric acid at this time point (Fig. 2 E). Western 
blot analysis revealed that splenocytes incubated 18 h in the 
presence  of DEX (90%  PI + cells) did not manifest a con- 
sistent reduction in the expression  of either subunits of mi- 
tochondrial  F1  ATPase, as  compared  to  fresh  splenocytes 
(Fig.  2 C).  This correlates  with the fact that, even at ad- 
vanced stages  of apoptosis,  when nuclear DNA was frag- 
mented, no degradation of mitochondrial DNA was observed 
(24,  25) and that, by consequence,  the number or mass of 
mitochondria did not diminish during PCD. 
To measure A~m ex vivo,  it is necessary to incubate the 
cells during a short period (10-15 min) at 37~  To deter- 
mine whether alterations in  A~I/m truly occur in vivo,  we 
intravenously injected the fluorochrome DiOC6(3)  animals 
pretreated with DEX (1  mg i.p.,  6 h before)  or PBS con- 
trols. After 45 rain of in vivo incubation, during which ani- 
mals did not display any signs of toxicity, splenic lympho- 
cytes were prepared on ice and analyzed by cytofluorometry 
without any prior culture. As shown in Fig. 3, a significant 
fraction of splenocytes from DEX-treated animals exhibited 
a lower AgSm-related fluorescence  than did cells from a ve- 
hicle control. 
In  synthesis,  a  reduction  in  A~m  accompanied DEX- 
induced PCD in vitro and in vivo. Kinetic data are compat- 
ible with the hypothesis that cells lose their AXIfm  first, and 
later undergo endonucleolysis, lipid peroxidation,  and cytolysis. 
Loss  in  z~ grm  Occurs  in  Cells  Irreversibly  Committed  to 
PCI~  To evaluate the relationship of diminished AxIf  m and 
apoptotic cell death, splenocytes from DEX-injected animals 
(500/~g i.p., 12 h before) were stained simultaneously with 
DiOC6(3) plus PI and separated into two fractions, a popu- 
lation of viable (PI-) cells with intact AXIfm (DiOC6(3)hig  h) 
and a yet viable  population with low A~m (DiOC6(3) l~ 
(Fig. 4 A). None of these populations exhibited oligonucleo- 
somal DNA fragmentation immediately after sorting. After 
short-term in vitro culture (60 min, 37~  DiOC6(3) l~ 
but not DiOC6(3) ~gh, cells showed typical ladder-type  oligo- 
el 
eL 
m 
I  control 
log  DiOC6(3) 
Figure  3.  In vivo determination of DEX-induced AXiOm  reduction. 
Mice were injected  with DEX (1 mg i.p.) or PBS. 6 h later, 10/~g of 
the fluorochrome  DiOC6(3)  l~  were injected into the tail vein, and, 45 
min later, splenocytes  were prepared on ice, as described  in Materials  and 
Methods, followed  by their immediate  cytofluorometric  analysis.  At the 
indicated dose, DiOC6(3) does not exhibit  any apparent in vivo toxicity. 
Figure 4.  Determination  of the status of nuclear DNA in cytofluoro- 
meter-purified populations  differing  in A~m. (A) Purification  of viable 
DiOC6(3)  1~  and DiOC6(3)hig  h populations. Splenic  T cells from a DEX- 
(500/~g) or PBS-injected  control animal were subjected to a combined 
PI/DiOC6(3) staining, followed  by FACS  |  purification  of DiOC6(3)  l~ 
and DiOC6(3)hig  h  cells, as indicated  by the windows. Cells were cultured 
60 rain at 4 or 37~  and DNA fragmentation  was assessed  by horizontal 
agarose gel electrophoresis. Results are representative for two indepen- 
dent experiments. 
nucleosomal DNA degradation (Fig. 4 B). Thus, it appears 
that  only the DiOC6(3)  l~  population is prone  to under- 
going apoptosis. 
To determine whether the loss in AxIr m would be revers- 
ible, cytofluorometer-purified  PI-DiOC6(3) ~~  splenic T  cells 
derived from a DEX-pretreated animal were incubated in the 
presence of cycloheximide, the GC receptor antagonist RU- 
38486,  and/or the cytokines IL-2 and/or IL-4, which have 
been reported to rescue T  cells from GC-induced apoptosis 
(26-29).  In spite of this manipulation, PI- DiOC6(3) l~  cells 
rapidly lost their viability upon in vitro culture (Fig. 5 A). 
As a positive control for the effectiveness of one of these 
manipulations, it is shown in Fig.  5 B that IL-4 and RU- 
38486  synergize to preserve the viability of splenocytes  un- 
dergoing PCD upon in vitro culture, either spontaneously, 
or as a consequence of a short-term in vivo exposure to DEX. 
In  synthesis,  loss  in  AxlI  m  accompanied  DEX-induced 
PCD at an already irreversible stage of apoptotic cell death. 
Ex Vivo Assessment of DEX- and Superantigen-induced Alter- 
ation of  A grin in Different Cell Populations.  The fluorochrome 
DiOC6(3)  emits within the spectrum  of green light and, 
thus, is compatible with the use of PE-labeled  antibodies. 
The combined assessment of  antigenic phenotype (CD3, CD4, 
CD8, IgM) and A~t'm reveals that treatment with high doses 
of DEX induces a loss in A~rm in splenic CD4 + and CD8 + 
T cells, splenic B cells, as well as thymocytes and bone marrow 
pre-B  cells  isolated  ex  vivo  (Fig.  6),  correlating with  a 
significant reduction in the cellularity of these populations. 
Similarly,  a reduction in A~m preceded  the PCD-mediated 
depletion of V~/8  + splenic T  cells 4 d after intravenous ad- 
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Figure  5.  Irreversibility of loss in 
A~'m. (.4) DiOC6(3)  l~  and DiOC6- 
(3)hig h  splenic T cells from a DEX- 
injected mouse were obtained  by cyto- 
fluorometric  purification as described  in 
Fig. 4 A, followed  by culture of cells 
at 37~  for 12 h in the presence of the 
GC receptor antagonist KU-38486 (10 
#M), IL-2 (100  U/ml), II.-4 (20 ng/ml) 
and/or cycloheximide  (50/~g/ml), and 
combined PI/DiOC6(3) staining. The 
percentage of cells that lost their via- 
bility (PI +  cells) immediately after 
sorting (25-40%) was subtracted. (B) 
Effect of KU-38486 and IL-4 on the 
maintenance of splenocyte  viability in 
vitro. Splenic  lymphocytes  from a PBS- 
injected control mouse or  a DEX- 
primed animal (2 h before necropsy) 
were cultured 12 h in the presence of 
RU-38486 (10 #M), I1:2 (100 U/ml) 
and/or IL-4 (20 ng/ml). Results  are typ- 
ical for  three different experiments. 
*  Significant (P <0.01) reduction of cel- 
lular mortality, as compared  to controls 
kept in the absence  of the indicated sub- 
stances. 
ministration  of the  bacterial  superantigen  SEB  (Fig.  7). 
Vfl6 + T cells that do not respond to SEB (3) failed to show 
an alteration  of A~m. 
Thus, reduced A~m is not a particularity of GC-induced 
PCD and also occurs during activation-induced PCD. In ad- 
dition,  nonspecific induction  of PCD, e.g., by injection of 
o-galactosamine (13), is also accompanied by reduced AXItm 
(data not  shown). 
Pharmacological Inhibition of A grm Reduction In Vivtx  The 
immunomodulator linomide inhibited the SEB-driven dele- 
tion ofVfl8 + T  cells (10). Accordingly, it fully inhibited the 
SEB-induced reduction in AXItm (Fig.  7). Moreover, linomide 
inhibited the DEX-driven depletion of splenic T and B lym- 
phocytes and mature CD3hig  a thymocytes (Reference 10 and 
Fig. 6), correlating with  the maintenance  of normal  AXItm 
levels. On the contrary, linomide failed to stabilize Aa/m of 
immature CD3  l~  thymocytes and bone marrow pre-B cells, 
which  both  succumbed  to  DEX,  irrespective  of whether 
animals  were treated with linomide  or not  (Fig.  6). 
These data suggest that linomide interferes with an early 
event of T lymphocyte PCD. To confirm this hypothesis, we 
determined further apoptosis-associated changes in cells from 
linomide-treated animals. After short-term culture (4 h, 37~ 
in  the  presence  of DEX,  splenic  T  cells  exhibited  early 
apoptosis-associated morphological changes (dilation of the 
smooth endoplasmatic reticulum, incipient heterochromatin 
condensation,  convolution of the nuclear membrane),  even 
when cells were kept in the presence of zinc ions at doses 
precluding  the  action  of Ca  2+-  and  Mg2+-dependent  en- 
donucleases (19).  This  was accompanied by fragmentation 
of DNA  into  large  (>~50-kb)  fragments  by zinc-resistant 
DNAses (18,  19).  Ceils from linomide-treated  animals did 
not  exhibit  these  PCD-associated  changes  (Fig.  8),  thus 
confirming that linomide inhibits a rather early step of the 
apoptotic cascade. 
Another substance that partially inhibits the DEX-mediated 
depletion of lymphocytes is NAC.  In contrast to linomide 
(10),  it acts on both immature  (CD4+CD8 +)  thymocytes 
and splenocytes (Fig.  9, A  and B). However, to obtain an 
apoptosis-inhibitory effect, NAC has to be administered at 
doses that,  per se, are toxic and provoke a significant lym- 
phopenia (Fig.  9 A).  NAC treatment  in vitro reduced the 
DEX-induced loss in DiOC6(3)  incorporation  (Fig.  9 C). 
ATA, an inhibitor of endonuclease activation, only partially 
reduces the DEX-induced lymphocyte depletion (Fig. IOA), 
even if it is administered at sublethal doses that inhibit the 
SEB-driven deletion of Vfl8 + thymocytes in vivo (12) and 
fully suppress DEX-induced DNA fragmentation  (Fig.  10 
B). ATA by itself reduces lymphocyte Aa/m, a finding that 
may explain its apparent toxicity. It fails to maintain the pool 
of cells with  an intact A~m.  Rather,  it inhibits  the cytol- 
ysis of DiOC6(3) l~  cells  (Fig.  10 C).  ATA did not confer 
long-term protection (>24 h) to lymphocytes cultured in the 
presence of DEX (data not  shown). 
In conclusion, efficient pharmacological inhibition of apop- 
tosis is accompanied by maintenance of stable A~m values. 
Inhibition of DNA endonucleases does not stabilize A~m. 
Rather,  it retards  the cytolysis of cells that  are irreversibly 
committed  to PCD. 
Concluding Remarks.  In the present paper, we demonstrate 
that peripheral lymphocytes exhibit a reduction in A~I/m  be- 
fore exhibiting other PCD-associated changes:  DNA frag- 
mentation  and concomitant  loss in nuclear DNA content, 
reduction of cell membrane potential, and membrane disrup- 
tion. Reduced AxIr m is the only alteration in cellular physi- 
ology accompanying GC-or activation-induced death of pe- 
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Figure  6.  Effect of DEX and linomide on the A~m of T and B lymphocytes  and their precursors.  DEX (500/~g i.p.) or PBS were injected into 
mice pretreated  with linomide or controls.  12 h later, splenocytes, thymocytes,  or bone marrow leukocytes were recovered, stained with the indicated 
PE-labeled mAbs, followed by a short-term incubation (15 min, 37~  with DiOC6(3).  Viable cells were gated on the basis of the light and forward 
scatters. Numbers indicate the percentage of cells found in the respective window. On the right, the cellularity of the respective populations  recovered 
18 h after  treatment with DEX and/or linomide is indicated. 
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Figure  7.  Effect of SEB and linomide on the 
A~I'm of splenic T  cells. SEB (50 #g i.v.) or 
PBS was injected into mice pretreated with lino- 
mide or controls.  4 d later, splenocytes were 
stained with biotin-labeled anti-V~8.1/2 or anti- 
VB6, revealed  with a PE-streptavidin conjugate 
and labeled with DiOCr(3).  Light and forward 
scatters were gated on viable cells. Numbers 
indicate  the proportion of DiOC6(3) l~  and 
DiOCr(3)hig  h cells. The percentages  refer to 
the entire V~8 + or V/~6+ population. Figure 8.  Effect oflinomide on early apop- 
totic changes. Splenocytes were recovered from 
linomide (LIN, L)-treated or control animals 
and incubated for 4 h in medium supplemented 
with 1 mM ZnCh in the presence or absence 
of 1 #M DEX (D). Aliquots of cells were sub- 
jeered to transmission electron microscopic anal- 
ysis (.4) or analyzed for high molecular weight 
DNA fragmentation by means of PAGE (B). 
Representative  calls out of 50  are shown. 
ripheral lymphoeytes  that  can be detected  directly ex vivo. 
Functional  analysis of preapoptotic cells exhibiting  reduced 
A~r  m  suggests that such cells are committed  to PCD,  given 
that they undergo DNA  fragmentation within as little as 1 h 
of culture and lyse, even when they are cultured in the pres- 
ence  of an  excess of RU-38486  (which  should  displace the 
apoptosis-inducing agent DEX  from the GC receptor)  (26) 
and cytokines that have been reported to block GC-induced 
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Figure  9.  Effect of NAC on DEX-induced lymphocyte depletion and reduction of A~m. (A) Effect of NAC on the DEX-triggered depletion of 
thymocytes and splenocytes in vivo. Animals were pretreated with NAC at the indicated dose for 24 h, before injection of DEX (500 #g i.p.). NAC 
application was continued for another 18 h, followed by immunofluorescence  analysis of splenic and thymic cell suspensions.  *Significant increase in 
NAC+DEX-treated animals over controls receiving DEX only. Data are representative for three independent experiments. (B) NAC partially rescues 
the DEX-induced deletion of CD4+CD8 + thymocytes. Thymic cell suspensions  from mice treated with DEX (500 #g i.p.) and/or NAC (3/~g/kg 
per d) were stained for CD4 and CD8 expression.  (C) Effect of NAC on the DEX-driven reduction of Af/m. Thymocytes were cultured with DEX 
(100 nM, from 2 to 12 h) and/or NAC (50 mM, from 0 to 12 h), followed by staining with PI and DiOC6(3).  *Significant effects of NAC on the 
maintenace  of A~m, as compared to cells cultured in the absence of NAC. 
1668  Mitochondrial Potential in Apoptosis Figure  10.  Effect of ATA on DEX-induced lymphocyte 
depletion and reduction of AIIr m  .  (A) Effect of ATA and/or 
DEX on the cellularity  of  lymphoid  organs. Animals received 
1.5 mg ATA twice (4 and 2 h before  DEX). 12 h after DEX 
(500 #g i.p.) injection, the cellularity  of the thymus  was deter- 
mined. (B) Assessment  of  DNA fragmentation on freshly  iso- 
lated thymocytes. (C) Effect of ATA on Aa/m. Thymocytes 
recovered from the animals treated with ATA and/or DEX 
were stained with PI and DiOC6(3), as shown in Fig. 9. 
PCD  (27-29).  Although  mitochondrial  DNA  is not  frag- 
mented  in  apoptotic  cells  whose  nuclear  DNA  has  been 
digested by endonucleases into oligonucleosomal fragments 
(24, 25), ultrastructural  changes in mitochondria occurring 
during  apoptosis have been detected (30).  Thymocytes un- 
dergoing DEX-induced PCD in vitro exhibit uncoupling of 
electron  transport  from ATP production,  correlating  with 
decreased  A~m,  and  similar  results  have  been obtained  in 
other systems of apoptosis induction (31, 32). Mitochondrial 
respiratory chain inhibitors  such as rotenone and antimycin 
A, as well as the highly specific mitochondrial ATP-synthetase 
inhibitor  oligomycin, induce PCD of many different mam- 
malian  cell types (33);  inhibition  of mitochondrial  protein 
synthesis with doxycline, as well as rotenone, render GC resis- 
tant cell lines sensitive to PCD induction by DEX (34, 35). 
These data argue in favor of the possibility that loss in m~tIlm 
and concomitant breakdown of mitochondrial respiration ac- 
tively participate in the apoptotic cascade.  The deficit in the 
generation of energy-rich phosphates may be expected to ul- 
timately cause cytolysis. However, at least at one stage of early 
PCD, that is represented by DEX-treated peripheral lympho- 
cytes isolated ex vivo (Fig.  1), loss in m~I/m precedes loss in 
cell membrane  potential  and  cytolysis. 
Cell lines  that  lack mitochondrial  DNA  and,  therefore, 
lack a functional respiratory chain are resistant to the induc- 
tion of death by drugs  such as rotenone,  antimycin A,  and 
oligomycin (33), yet are susceptible to the induction of apop- 
tosis by growth factor withdrawal (36). Although these data 
suggest that ethidium bromide--selected cell lines relying on 
anaerobic glycolysis may undergo  PCD in the absence of a 
modulation of their respiratory function, they do not exclude 
the possibility that, under physiological  conditions, mitochon- 
dria are involved in PCD execution. In this context, it is in- 
triguing  that  cells  lacking  mitochondrial  DNA do possess 
mitochondria that retain important functions, including suc- 
cinate dehydrogenase activity (37) and generation of a near- 
normal electrochemical  gradient  (including  A~m),  that,  in 
contrast to normal cells, depends on glycolytic ATP genera- 
tion  (38). 
The capacity of drugs (linomide,  NAC,  ATA)  to inhibit 
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lymphocyte depletion in vivo correlates well with their poten- 
tial to stabilize A~m.  NAC is a well-established thiol anti- 
oxidant,  which,  after  uptake,  deacylation,  and  conversion 
to glutathione,  functions as both a redox buffer and a reac- 
tive oxygen intermediate  scavenger.  NAC has been reported 
to prevent or postpone the death of cell lines deprived from 
essential growth factors (16),  as well as the antigen-driven 
apoptosis of hybridomas (39). In accord with its limited effect 
on DEX-driven lymphocyte depletion, NAC partially inhibits 
the  DEX-driven  loss in  A~m.  Similarly  to  NAC,  overex- 
pression of the protooncogene product Bcl-2, a protein that 
is  thought  to protect  against  apoptosis via an  antioxidant 
pathway (16),  has been shown to actively enhance AIICm  in 
transfected cells and prevents AXXlm  loss induced by TNF-ot 
in vitro (40).  High expression of Bcl-2 also correlates with 
enhanced ATP generation by mitochondria (35).  In addition, 
short-term  exposure  of cells  to  H202 for  several  minutes, 
causes an immediate  reduction  in  A~m  (data  not  shown). 
These data suggest that  reactive oxygen species  may be in- 
volved in  the  disruption  of A~m. 
Although antioxidants  contribute to maintain  A~m,  sev- 
eral observations reported in this paper suggest that the ac- 
cumulation and/or action of reactive oxygen species are sec- 
ondary  to  the  breakdown  of  A~m.  First,  when  m~I/m is 
decreased in cells recovered from DEX-treated  animals,  the 
concentration of intracellular  hydroperoxide is normal (Fig. 
1). Second, lipid peroxidation induced by DEX in vitro can 
be detected only after m~Xtm  is lost (Fig.  2 E).  To integrate 
these data,  it is tempting  to speculate that both events, loss 
in Aff'm and accumulation/action  of reactive oxygen species, 
could result in a self-amplification loop in which disruption 
of the mitochondrial compartments favors the accumulation 
of radicals  and radical-mediated damage, as well as the break- 
down of respiratory metabolism, and that, together, they par- 
ticipate  in  the  execution of PCD. 
ATA, an agent that, among other effects, inhibits the acti- 
vation of DNA endonucleases, also partially protects against 
DEX-induced lymphocyte depletion in vivo. ATA, by itself, 
reduces the lymphocyte A~m, both in vivo (Fig.  10) and in 
vitro (not shown), and fails to inhibit the DEX-induced reduc- tion in AXItm, but retards the cytolysis of AXI'm  l~  cells. These 
data are compatible with the finding that ATA maintains lym- 
phocyte viability during in vitro short-term cultures (12), al- 
though it fails to preserve the mitochondrial function of anti- 
CD3-stimulated T  cell hybridomas (41). The fact that ATA 
can inhibit DNA fragmentation without preserving lymphoid 
organ cellularity and A~I/m (Fig.  10),  as well as the kinetic 
data (Fig.  2),  clearly indicates  that  DNA fragmentation  is 
not a primary event of PCD. In accordance with this notion, 
substances other than ATA that block DNA fragmentation 
are also incapable of providing long-term protection against 
cytolysis: zinc (18, 42), calcium chelators (19, 43), and ene- 
diynes (44). In contrast to ATA, an apoptosis-inhibitory agent 
that operates via yet unknown mechanisms,  linomide (10), 
stabilizes A~m in those cell populations  that are protected 
against DEX or superantigen-driven  depletion: peripheral lym- 
phocytes and mature (CD3hig h) thymocytes, but not imma- 
ture (CD3 l~  T  and B cell precursors from the thymus and 
the bone marrow. Moreover, it interferes with relatively early 
(zinc inhibitable)  apoptosis-associated changes in the mor- 
phological appearance of splenic T cells and with the degra- 
dation  of DNA into large fragments  of i>50 kb. 
In synthesis, our data are compatible with the following 
sequence of catabolic PCD-associated events. After an initial 
phase of commitment  to PCD, which can be inhibited by 
linomide, growth factors, interventions on signal transduc- 
tion (45), exogenous antioxidants, and Bcl-2 (40), mitochon- 
drial function is perturbed,  perhaps via a regulated process 
(46), or perhaps  as a consequence of the opening of mito- 
chondrial  permeability  transition  pores  or  mitochondrial 
megachannels,  accompanied by a partial,  yet irreversible reduc- 
tion in Aff'm. Opening of such megachannels situated in the 
inner mitochondrial membrane has indeed been reported to 
contribute to the death of anoxia-damaged myocardial cells 
(47).  As an alternative,  reduced A~I/m might  be secondary 
to alterations  in glucose alterations,  as they have been reported 
for growth factor-deprived cells (48). Reduced Aff'm marks 
an irreversible early event in the cascade of metabolic events 
accompanying PCD. In cells that already are irreversibly com- 
mitted to PCD and whose A~ICm  is reduced, inhibitors of en- 
donucleolysis  may  still  retard  cytolysis.  Recognition  and 
removal of peripheral lymphocytes undergoing PCD by ad- 
jacent cells would intervene after the loss of A~m,  but be- 
fore later PCD-associated changes occur. Thus,  cytofluoro- 
metric measurement of A~Itm provides a tool for the ex vivo 
assessment of PCD. These findings have major implications 
for the detection, as well as the modulation, of PCD in vivo. 
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